1-5 of 5
Rafee Talukder, MD
Close
Sort by
Journal Articles

Serum Lipidome and Glucose Metabolism Uncover Vulnerabilities in Myelodysplasia and Secondary Acute Myelogenous Leukemia

Samer Al Hadidi, MD MSc, FACP, Rafee Talukder, MD, Gustavo A. Rivero, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–34.
https://doi.org/10.1182/blood-2020-143332
Published: 2020
Journal Articles

Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk Stratification

Aimaz Afrough, MD, Rafee Talukder, MD, Sarvari Venkata Yellapragada, MD, Purnima Sravanti Teegavarapu, MD, Martha P. Mims, MD PhD, Gustavo A. Rivero, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2678.
https://doi.org/10.1182/blood-2019-129183
Published: 2019
Journal Articles

Superior Outcome in Elderly AML Patients Receiving Adjuvant Serotonin-Reuptake-Inhibitors during Induction

Rafee Talukder, MD, Martha P. Mims, MD PhD, Gustavo A. Rivero, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1438.
https://doi.org/10.1182/blood-2019-131581
Published: 2019
Journal Articles

Predictors of Survival in Myelodysplastic Patients with Cardiovascular Disease

Gustavo A. Rivero, MD, Vera Schroeder, Sandra Carias, Rafee Talukder, MD, Pedro Emilio Alcedo, MD, Anna Frolov, M.S., M.A
Journal: Blood
Blood (2018) 132 (Supplement 1): 4386.
https://doi.org/10.1182/blood-2018-99-120267
Published: 2018
Journal Articles

Predictive Factors for Complete Remission and Survival in AML Patients Failing to Achieve Adequate Bone Marrow Day 14 Blast Eradication

Rafee Talukder, MD, Sarvari Venkata Yellapragada, MD, Hussein Hamad, MD, Gustavo A. Rivero, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1464.
https://doi.org/10.1182/blood-2018-99-115830
Published: 2018